Medicine & Life Sciences
Retinal Pigments
100%
Glutaredoxins
83%
human GLRX protein
59%
N-(11-cyano-2,2,6a,6b,9,9,12a-heptmethyl-10,14-dioxo-1,3,4,5,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydro-2H-picen-4a-yl)-2-2-difluoropropionamide
59%
Epithelial Cells
58%
NF-E2-Related Factor 2
48%
salvianolic acid B
43%
penicillamine-glutathione mixed disulfide
41%
Oxidative Stress
39%
Coronavirus
34%
Triterpenes
34%
Noncommunicable Diseases
31%
Herbal Medicine
30%
Medication Adherence
30%
Rural Population
29%
Traditional Medicine
28%
South Africa
28%
Eye Diseases
28%
Health Expenditures
27%
Antioxidants
22%
Cell Death
20%
Costs and Cost Analysis
19%
Macular Degeneration
17%
Wounds and Injuries
16%
Diabetic Retinopathy
14%
Oxidants
14%
Blindness
14%
Health
13%
Human Body
13%
Hypoglycemic Agents
12%
Glaucoma
12%
Cataract
12%
Medicine
11%
Apoptosis
10%
Confidence Intervals
10%
Glutathione Disulfide
10%
Odds Ratio
9%
Small Interfering RNA
9%
Eye
8%
Delivery of Health Care
7%
Mortality
7%
Hispanic Americans
6%
Mathematical Computing
6%
European Continental Ancestry Group
6%
Income
6%
Health Services
6%
Economics
6%
Propidium
5%
Proto-Oncogene Proteins c-akt
5%
Cell Survival
5%
Chemical Compounds
Retinal Pigment
73%
Salvianolic Acid B
43%
Glutaredoxin
41%
Ocular
34%
Triterpenoid
32%
Cell Death
29%
Oxidative Stress
27%
Antioxidant Agent
20%
Glutathione
7%
Cytoprotective
7%
Propidium Iodide
7%
Protective
7%
Silencing RNA
7%
Cell Viability
5%
Social Sciences
traditional medicine
36%
chronic illness
26%
medication
26%
rural community
25%
utilization
24%
expenditures
23%
Republic of South Africa
20%
costs
17%
medicine
11%
possession
6%
regression
6%
confidence
5%
drug
5%
adverse events
5%
income
5%